Similar total STAT3 immunostaining was observed in both vehicle-treated and WP1066-treated tumours, suggesting that WP1066 inhibited phosphorylation of STAT3 without modulating STAT3 expression (Figure 5C, middle row). This evidence concerns the gene STAT3 and neoplasm.